We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+26.89%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$352M
AUM Growth
+$55.2M
Cap. Flow
+$908K
Cap. Flow %
0.26%
Top 10 Hldgs %
80.62%
Holding
64
New
1
Increased
7
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$3.25M
2
PGNY icon
Progyny
PGNY
+$2.09M
3
MNDY icon
monday.com
MNDY
+$1.98M
4
GTM
ZoomInfo Technologies
GTM
+$1.84M
5
HOOD icon
Robinhood
HOOD
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 57.14%
2 Consumer Discretionary 23.1%
3 Healthcare 10.67%
4 Financials 3.27%
5 Communication Services 1.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPTX
51
DELISTED
Repare Therapeutics
RPTX
$130K 0.04%
12,276
RLYB icon
52
Rallybio
RLYB
$85.3M
$124K 0.04%
2,735
RYTM icon
53
Rhythm Pharmaceuticals
RYTM
$7.39B
$93K 0.03%
5,639
IPSC icon
54
Century Therapeutics
IPSC
$372M
$91.7K 0.03%
29,018
PMVP icon
55
PMV Pharmaceuticals
PMVP
$58.7M
$72.2K 0.02%
11,533
ASTR
56
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$68.8K 0.02%
12,444
ALGS icon
57
Aligos Therapeutics
ALGS
$26.7M
$18.2K 0.01%
751
NXTC icon
58
NextCure
NXTC
$20.5M
$18.1K 0.01%
837
LOV
59
DELISTED
Spark Networks SE American Depositary Shares
LOV
$16.4K ﹤0.01%
52,175
-52,053
-50% -$42K
GRNA
60
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$14.6K ﹤0.01%
48,835
SMRT icon
61
SmartRent
SMRT
$201M
-220,318
Closed -$562K
THCH icon
62
TH International
THCH
$51.3M
-119,385
Closed -$2.43M
VYGR icon
63
Voyager Therapeutics
VYGR
$189M
-61,776
Closed -$476K
SUMO
64
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
-127,788
Closed -$1.53M

Similar funds

Harbourvest Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Harbourvest Partners held 64 positions worth $352M, up 19% from $297M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Harbourvest Partners's Q2 2023 filing shows 1 new, 7 increased, 6 reduced and 4 closed positions. Its largest new stake was Pliant Therapeutics: 49,434 shares worth $896K. The largest sale was N-able, an estimated $4.41M.

By sector, the portfolio is most concentrated in Technology at 57% of assets, down from 60% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Harbourvest Partners's largest Q2 2023 buy was Pliant Therapeutics: 49,434 shares worth $896K.
  • Harbourvest Partners added most to Affirm in Q2 2023, an estimated $3.25M increase.
  • Harbourvest Partners's biggest Q2 2023 reduction was N-able, cutting an estimated $4.41M.
  • Harbourvest Partners fully exited TH International in Q2 2023, selling an estimated $2.43M.
  • Harbourvest Partners's ten largest holdings make up 81% of its $352M portfolio in Q2 2023.
  • Harbourvest Partners opened 1 new position and closed 4 in Q2 2023.
  • Harbourvest Partners's portfolio value rose 19% quarter-over-quarter to $352M.

Based on Harbourvest Partners's 13F filing for Q2 2023, filed 14 Aug 2023.